SLC7A11-IN-1

SLC7A11-IN-1

• CAS Number: 3049302-90-8
• UNSPSC Description: SLC7A11-IN-1 is a potent solute carrier family 7 member 11 (SLC7A11, xCT) inhibitor. SLC7A11-IN-1 shows antiproliferative activity. SLC7A11-IN-1 inhibits cell invasion and metastasis. SLC7A11-IN-1 induces Apoptosis and cell cycle arrest at S-phase. SLC7A11-IN-1 shows anti-tumor activity[1].
• Target Antigen: Apoptosis
• Type: Reference compound
• Related Pathways: Apoptosis
• Applications: Cancer-programmed cell death
• Field of Research: Cancer
• Assay Protocol: https://www.medchemexpress.com/slc7a11-in-1.html
• Solubility: DMSO : ≥ 20 mg/mL
• Smiles: [NH3][Pt+4]([OH-])([Cl-])([Cl-])([O-]C(CCCC(NC1=NC2=CC=C(C=C2S1)OC(F)(F)F)=O)=O)[NH3]
• Molecular Weight: 664.35
• References & Citations: [1]Li Z, et al. Blocking xCT and PI3K/Akt pathway synergized with DNA damage of Riluzole-Pt(IV) prodrugs for cancer treatment. Eur J Med Chem. 2023 Mar 15;250:115233.
• Shipping Conditions: Room Temperature
• Clinical Information: No Development Reported